Wall Street shares set to start on front foot, buoyed by Google; European shares also higher
The Dow Jones Industrial Average closed down around 13 points at 25,044 but today futures are up 87 points.
Company
Eli Lilly and Co
NYSE:LLY
Eli Lilly and Co is engaged in drug manufacturing businesses. The company discovers, develops, manufactures and markets products in the human pharmaceutical products segment.
147 stories · page 6 of 8
AstraZeneca and Eli Lilly halt late-stage Alzheimer’s study as drug shows no sign of working
AstraZeneca and Lilly’s lanabecestat drug can be added to the list of failed Alzheimer’s treatments; in fact, 99% of all drugs developed to treat the disease have failed clinical trials in the past ten years
Eli Lilly 1Q earnings beat Street, but FDA delivers disappointing recommendation for new arthritis drug
An FDA advisory committee does not recommend use of arthritis drug baricitinib at a higher dosage
Eli Lilly in tie-up with Sigilon for diabetes treatment
The pharma giant will take a charge of US$0.05 a share in the second quarter as a result of the transaction
Apricus goes flat as FDA refuses to approve erectile dysfunction treatment
It’s the second time regulators have given the thumbs-down to Vitaros, with the FDA flagging concerns over one of the ingredients in the cream as well as with the manufacturing process
Anthem Inc, Eli Lilly and Co, Tupperware Brands and more - PRE-MARKET
Proactive takes a look at what's moving the needle in pre-market ahead of what looks like an earnings-fuelled day
Lilly expects low-dingle-digit revenue growth in 2018
Strong demand for its recently-launched products including its new diabetes and psoriasis drugs is likely to push up sales next year
Eli Lilly shares higher after third quarter results beat market expectations
The drugmaker also told investors that it was looking at various options, including the possible sale or even an IPO for its Elanco Animal Health business
Eli Lilly & Co shares higher as migraine drug findings cheer
The detailed results from the 12-month, open-label Phase 3 study will be presented today
AMC Entertainment, Eli Lilly, ADP - PRE-MARKET
Just days after cinemas owner issued a profit warning it released its second quarter numbers, and they were not quite the horror picture the market had been expecting
Eli Lilly and Co. shares boosted by successful trial of migraine drug lasmiditan
Eli Lilly and Co. will apply for approval of lasmiditan in the second half of next year
Cogstate Ltd to update on submission to U.S. FDA
The halt will remain in place until Friday 28th July 2017.
Eli Lilly on back-foot despite better than expected results
A delay for a new drug application somewhat overshadowed better than expected results.
Eli Lilly /Pfizer back pain treatment gets fast track status from US Food and Drug Administration
A phase III trial is currently underway and includes six studies in 7,000 patients suffering osteoarthritis, chronic low back pain and cancer.
Eli Lilly says Cyramza meets bladder cancer phase III endpoint
Some 531 patients with urothelial carcinoma were treated in the trial
Wall Street shares close firmly higher
US benchmarks closed higher on Tuesday as traders await more on Trump's tax plans
Eli Lilly reports endpoint success in advanced breast cancer trial
Abemaciclib is also being tested in trials for for lung cancer, brain metastases and pancreatic cancer.
Pharma giant Eli Lilly shares plummet in pre-market on arthritis drug news
Rheumatoid arthritis affects the joints and more than 23mln people worldwide
Eli Lilly reassures with full-year earnings guidance
The fourth quarter EPS was a little shy of expectations, but the shares still rose
Eli Lilly perks up on better than expected guidance
Growth in its portfolio of new products was behind the better than expected forecasts.